Toshinobu Kubota1, Suzuko Moritani, Shu Ichihara. 1. Department of Ophthalmology, Nagoya Medical Center, 4-1-1, Sannomaru, Naka-ku, Nagoya-shi, Aichi-ken 460-0001, Japan. ganiky@nnh.hosp.go.jp
Abstract
BACKGROUND: A primary ductal adenocarcinoma of the lacrimal gland is a rare epithelial malignant tumor, and its clinicopathological and immunohistochemical features have not been well determined. The purpose of this study was to determine the clinicopathological characteristics of lacrimal duct carcinomas and to determine their long-term prognosis. METHODS: We performed immunohistochemical studies of biological and proliferative markers of primary ductal adenocarcinomas of the lacrimal gland in five patients, and followed their long term prognosis. We also reviewed nine published cases of primary ductal adenocarcinomas of the lacrimal gland. RESULTS: All specimens were positive for the androgen receptor, and three of five specimens overexpressed the HER-2/neu protein. Nuclear immunostaining for p53 ranged from 10% to 95% and that of Ki-67 from 20% to 70% in the tumor cells. Four of five patients had distant metastases and three patients died from the disease during the 5-year follow-up. CONCLUSIONS: Our findings indicate that primary ductal adenocarcinomas of the lacrimal gland express androgen receptors and a wide range of proliferative markers. Their long-term prognosis is poor.
BACKGROUND: A primary ductal adenocarcinoma of the lacrimal gland is a rare epithelial malignant tumor, and its clinicopathological and immunohistochemical features have not been well determined. The purpose of this study was to determine the clinicopathological characteristics of lacrimal duct carcinomas and to determine their long-term prognosis. METHODS: We performed immunohistochemical studies of biological and proliferative markers of primary ductal adenocarcinomas of the lacrimal gland in five patients, and followed their long term prognosis. We also reviewed nine published cases of primary ductal adenocarcinomas of the lacrimal gland. RESULTS: All specimens were positive for the androgen receptor, and three of five specimens overexpressed the HER-2/neu protein. Nuclear immunostaining for p53 ranged from 10% to 95% and that of Ki-67 from 20% to 70% in the tumor cells. Four of five patients had distant metastases and three patients died from the disease during the 5-year follow-up. CONCLUSIONS: Our findings indicate that primary ductal adenocarcinomas of the lacrimal gland express androgen receptors and a wide range of proliferative markers. Their long-term prognosis is poor.
Authors: Songlin Piao; Shu Zhao; Fulin Guo; Jie Xue; Guodong Yao; Zhili Wei; Qi Huang; Yao Sun; Bin Zhang Journal: J Cancer Res Clin Oncol Date: 2012-01-04 Impact factor: 4.553
Authors: Tatyana Milman; Jerry A Shields; Michael Husson; Brian P Marr; Carol L Shields; Ralph C Eagle Journal: Ophthalmology Date: 2005-11 Impact factor: 12.079
Authors: Michael Jaehne; Kerstin Roeser; Thorsten Jaekel; Jan David Schepers; Natalie Albert; Thomas Löning Journal: Cancer Date: 2005-06-15 Impact factor: 6.860
Authors: Ezekiel Weis; Jack Rootman; Thomas J Joly; Kenneth W Berean; Hind M Al-Katan; Sylvia Pasternak; Giulio Bonavolontà; Diego Strianese; Peerooz Saeed; Kenneth A Feldman; Sumalee Vangveeravong; Jocelyne S Lapointe; Valerie A White Journal: Arch Ophthalmol Date: 2009-08
Authors: Thonnie Rose O See; Gustav Stålhammar; Tina Tang; Joshua S Manusow; David R Jordan; Jeffrey A Nerad; Robert C Kersten; Marc Yonkers; Nasreen A Syed; Seymour Brownstein; Hans E Grossniklaus Journal: Surv Ophthalmol Date: 2019-12-16 Impact factor: 6.048